Results 1 to 10 of about 359,605 (263)
Liver metastasis or a pseudocyst? A rare presentation of leiomyosarcoma’s metastasis in the liver
Contemporary Oncology, 2023 Gastrointestinal neoplasms most commonly metastasize to the liver, where they are typically found as solid and hypervascular lesions. Here, we describe a case of a 44-year-old man with a leiomyosarcoma of the rectum, who at the time of diagnosis ...
Adrian Bednarek +7 more
doaj +3 more sources
Molecular mechanism and potential therapeutic targets of liver metastasis from gastric cancer
Frontiers in Oncology, 2022 Gastric cancer (GC) is characterized by high invasion and poor prognosis. The occurrence of liver metastasis seriously affects advanced GC prognosis. In recent years, great progress has been made in the field of GC liver metastasis.
Difeng Li +4 more
doaj +3 more sources
SLC38A4 promotes Kupffer cell phagocytosis and suppresses tumor liver metastasis [PDF]
Experimental and Molecular MedicineMetastasis is the main cause of cancer-related death. The liver is an organ with high metastatic tropism for various malignancies. Hepatic-resident macrophage Kupffer cells are the major non-parenchymal cells in the liver that phagocytize disseminated ...
Jie Li +14 more
doaj +2 more sources
Liver Metastasis in Cancer: Molecular Mechanisms and Management
MedCommLiver metastasis is a leading cause of mortality from malignant tumors and significantly impairs the efficacy of therapeutic interventions. In recent years, both preclinical and clinical research have made significant progress in understanding the ...
Wenchao Xu +5 more
doaj +2 more sources
Neuroendocrine liver metastasis. [PDF]
Hepatobiliary Surg NutrWalia S, Roch AM, Ceppa EP.
europepmc +5 more sources
Comprehensive analysis of complement-associated molecular features in hepatocellular carcinoma
Acta Biochimica et Biophysica Sinica, 2022 The complement cascade plays a “complementing” role in human immunity. However, the potential roles of complement system in impacting molecular and clinical features of hepatocellular carcinoma (HCC) remain unclear.
Huang Run +13 more
doaj +1 more source
Journal for ImmunoTherapy of Cancer, 2021 Background Hepatocellular carcinoma (HCC) is characterized by inflammation and immunopathogenesis. Accumulating evidence has shown that the cystathionine β-synthase/hydrogen sulfide (CBS/H2S) axis is involved in the regulation of inflammation.
Jian Zhou +15 more
doaj +1 more source
Current landscape and perspective of oncolytic viruses and their combination therapies
Translational Oncology, 2022 Oncolytic virotherapy has become an important strategy in cancer immunotherapy. Oncolytic virus (OV) can reshape the tumor microenvironment (TME) through its replication-mediated oncolysis and transgene-produced anticancer effect, inducing an antitumor ...
Yinghan Su, Changqing Su, Lunxiu Qin
doaj +1 more source
Cell Discovery, 2023 Mixed lineage kinase domain-like (MLKL) is widely accepted as an executioner of necroptosis, in which MLKL mediates necroptotic signaling and triggers cell death in a receptor-interacting protein kinase 3 (RIPK3)-dependent manner.
Xifei Jiang +24 more
doaj +1 more source
World Journal of Surgical Oncology, 2023 Background Liver stiffness relates to more advanced tumor status and poor outcomes in primary liver cancer, while its prognostic role in pancreatic cancer with liver metastasis is unclear.
Shu Dong +5 more
doaj +1 more source